Also of importance, and beyond the scope of the current 2D cell culture assays (Figs. 4 and EV4), is understanding the impact of CBP/p300-enhanced NRF2 redox signaling on cancer cell invasion/migration within the framework of metastatic disease progression, ultimately in in vivo systems. The gene discussed is NFE2L2; the disease is cancer.